Latest filing published 17 Apr 2024 for Lyka Labs Limited, €4.1M.
Insider track record
Ipca Laboratories Limited: trading record in brief
Ipca Laboratories Limited discloses dealings in Lyka Labs Limited to SEBI (PIT + SAST). In total, 5 filings cover trades dated from 23 February 2022 to 16 April 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 17 April 2024, the filings show a transaction worth €4.1M in Lyka Labs Limited. The median gap between a trade and its publication by SEBI (PIT + SAST) is 1 day. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ipca Laboratories Limited
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,600,000 shares@ ₹139.5021.6% of flowEquity SharesSEBI:5b972d34b6d36afd06378a6499cb2efa13044026
- 2,400,000 shares@ ₹139.5019.7% of flowEquity SharesSEBI:8637f3e45daa8e5b8a1150a70d884c9f1de99054
- 2,000,000 shares@ ₹139.5016.8% of flowEquity SharesSEBI:4a3e7510b98d55755b5491b267f575af08a8aed6
- 5,000,000 shares@ ₹139.5041.9% of flowWarrantsSEBI:4d56f13ec5b82fde5629ca4bf6c2e391c04d5e05
- 781 shares@ ₹130.50060.0% of flowEquity SharesSEBI:5ad356359be155ce0e4f586dc066f504ad889ea4
5 of 5 declarations